In the heart we demonstrate that blocking glucagon signalling can significantly enhance cardiac insulin sensitivity and enhance insulin-stimulated glucose oxidation which improves cardiac energy production in the MI hearts. This evidence concerns the gene GCG and myocardial infarction.